Gene · 27343
Papers1,899
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,899
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA polymerase kappa is the primary translesion synthesis polymerase for aldehyde ICLs. | Nucleic Acids Res | 2025 | 40985768 | PubTator, text mining | PubMed |
| Genetic analysis of thalassemia in putian: comparative insights into mutation spectra with other global regions. | Ann Hematol | 2025 | 40970927 | PubTator, text mining | PubMed |
| Biochemical reconstitution of temozolomide-induced mutational processes. | J Biol Chem | 2025 | 40914245 | PubTator, text mining | PubMed |
| WRN and WRNIP1 ATPases impose high fidelity on translesion synthesis by Y-family DNA polymerases. | Elife | 2025 | 40900148 | PubTator, text mining | PubMed |
| Identification of a PCNA-binding motif in human translesion DNA polymerase REV1 and structural basis of its interaction with PCNA. | J Biochem | 2025 | 40888629 | PubTator, text mining | PubMed |
| NSUN2 facilitates DICER cleavage of DNA damage-associated R-loops to promote repair. | Nat Commun | 2025 | 40849328 | PubTator, text mining | PubMed |
| Integration of Immune Cell Signatures and Diagnostic Gene Markers in Pancreatitis: A Comprehensive Study on Therapeutic Targets and Predictive Diagnosis. | Hum Mutat | 2025 | 40787634 | PubTator, text mining | PubMed |
| Comprehensive review on Fanconi anemia: insights into DNA interstrand cross-links, repair pathways, and associated tumors. | Orphanet J Rare Dis | 2025 | 40739565 | PubTator, text mining | PubMed |
| Editor's Note on 'Error-free bypass of 2-hydroxyadenine by human DNA polymerase λ with Proliferating Cell Nuclear Antigen and Replication Protein A in different sequence contexts'. | Nucleic Acids Res | 2025 | 40737096 | PubTator, text mining | PubMed |
| [Analysis of hematological characteristics of patients with three common deletional β-thalassemias and concomitant α-thalassemia in Huizhou, Guangdong province]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2025 | 40350389 | PubTator, text mining | PubMed |
| [Analysis of the Results of Thalassemia Gene Screening in 9 334 Cases in Guiyang Region]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2025 | 40326123 | PubTator, text mining | PubMed |
| Theoretical solution research on air curtain thermal insulation technology at tunnel portal in cold area. | Sci Rep | 2025 | 40082476 | PubTator, text mining | PubMed |
| Prevalence and molecular spectrum of thalassemia in infertile population among different ethnic groups in Hainan Province, China. | Mol Genet Genomics | 2025 | 40053127 | PubTator, text mining | PubMed |
| Translesion-synthesis-mediated bypass of DNA lesions occurs predominantly behind replication forks restarted by PrimPol. | Cell Rep | 2025 | 40014449 | PubTator, text mining | PubMed |
| Search for germline gene variants in colorectal cancer families presenting with multiple primary colorectal cancers. | Int J Cancer | 2025 | 39654522 | PubTator, text mining | PubMed |
| Catalytic and noncatalytic functions of DNA polymerase κ in translesion DNA synthesis. | Nat Struct Mol Biol | 2025 | 39300172 | PubTator, text mining | PubMed |
| Screening and Diagnosis of Rare Thalassemia Variants: Is Third-Generation Sequencing Enough? | Arch Pathol Lab Med | 2025 | 38649152 | PubTator, text mining | PubMed |
| [Analysis of genetic diagnosis results of 1 501 suspected Cases of thalassemia patients from 2020 to 2022]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2024 | 39743275 | PubTator, text mining | PubMed |
| [Application Analysis of Screening for Thalassemia in the Population of Childbearing Age in Quanzhou]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2024 | 39743274 | PubTator, text mining | PubMed |
| PARylation of GCN5 by PARP1 mediates its recruitment to DSBs and facilitates both HR and NHEJ Repair. | Cell Mol Life Sci | 2024 | 39508866 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/27343/papers?page=2